~~<i id='59C5CFB867'><strike id='59C5CFB867'><tt id='59C5CFB867'><pre id='59C5CFB867'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

entertainment

author：explore 2025-10-01 02:27:55 - browse：429

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Anesthesiologist group: stop taking Ozempic before surgery
Next article： FDA warns medical device makers about rise in fabricated data

entertainment

hotspot

entertainment

focus

leisure time

knowledge

AdobeGroundbreakingresearchmorethanadecadeagoshowedthatalmostone-fifthofpeopleenrolledinMedicarewere

WSS

Discs beat pads, tampons for heavy menstrual flow, new study shows

Biden praises World Series champion Astros for impact off the field during White House celebration

Bipartisan group of lawmakers warns of a rising Chinese threat to U.S. biotech

The painfully weak evidence on taking collagen to treat arthritis

MD Anderson's Padmanee Sharma responds to research credit suit

The painfully weak evidence on taking collagen to treat arthritis

focus

entertainment

entertainment

Tori Bowie and the unacceptable rates of Black maternal death

Former Georgia lieutenant governor says he received grand jury subpoena

BioMarin wins approval for gene therapy to treat hemophilia A

Former Georgia lieutenant governor says he received grand jury subpoena

Hepatitis C has a cure — but many Americans still lack access to it

Flagship Pioneering startup Sonata Therapeutics lays off 21

In Memoriam: Notable people who died in 2023

New CMS data security rules will hurt Medicare, Medicaid research

Heart attack and stroke risk calculators need revising

Sage's campaign to raise awareness of postpartum depression hits a nerve

hotspot

Wegovy cuts risk of cardiovascular events by 20%, study finds

Sage's campaign to raise awareness of postpartum depression hits a nerve

An Ebola outbreak presents a new mystery involving children

In venture capital firm's success, lessons for turning crisis into profit

'Of course' Trump lost the 2020 election, DeSantis says after years of hedging

Flagship Pioneering startup Sonata Therapeutics lays off 21

entertainment

focus

leisure time

knowledge